Table 1.
Clinical characteristics of the study populations
| Variables | Value |
|---|---|
| Age | 59.5 ± 13.08 |
| Gender | |
| Male/Female | 258/189 |
| Location | |
| Colon/Rectal | 224/223 |
| Histological grade | |
| High/Middle/Low | 53/86/308 |
| T stage | |
| T1/T2/ T3/ T4/ TX | 7/52/102/251/35 |
| N stage | |
| N0/N1/N2/N3 | 152/160/89/46 |
| M stage | |
| M0/M1/MX | 279/157/11 |
| White blood cells | 6.36 (5.14–8.10) |
| Hemoglobin | 118.5 (102.2–130.1) |
| Platelet | 271.3 (215.5–339.5) |
| Neutrophil | 3.85 (2.93–5.23) |
| Lymphocyte | 1.62 (1.27–2.03) |
| ALB | 36.60 (33.90–39.30) |
| CEA | 3.11 (1.21–17.71) |
| CA125 | 10.80 (7.10–25.15) |
| CA153 | 8.50 (4.95–12.95) |
| CA199 | 16.60 (8.15–39.55) |
| T lymphocyte | 65.10 (59.70–71.25) |
| B lymphocyte | 12.70 (9.40–16.20) |
| NK | 15.60 (11.45–20.20) |
| CRP | 3.31 (1.34–11.29) |
| hsCRP | 0.83 (0.42–3.85) |
| NLR | 2.29 (1.65–3.43) |
| PLR | 165.42 (119.81–242.77) |
| CAR | 0.09 (0.03–0.32) |
NK Natural killer, CEA Carcinoembryonic antigen, ALB Albumin, CRP C-reactive protein, hsCRP High sensitivity C-reactive protein, NLR Neutrophil-lymphocyte ratio, PLR Platelet lymphocytes ratio, CAR CRP/ALB ratio